Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 1, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 4
- 0 vs. Q3 2023
- Portfolio value
- $157.7M
- +$90.6M (+135.0%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AUTLAutolus Therapeutics plc | SPON ADS | 21,346,829 | $137.5M | 87.1% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $9.86M | 6.2% | 00.0% | Unchanged | – |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,466,507 | $9.33M | 5.9% | 00.0% | Unchanged | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $1.09M | 0.7% | 00.0% | Unchanged | History |